Top Institutions in Infectious Disease
The ranking is based on the institutions' involvement in the DOTS randomized trial, their leadership roles in relevant research programs, clinical trial activity, and recent peer-reviewed publications related to dalbavancin and bacteremia.
-
#1
Duke University School of Medicine / Duke Clinical Research Institute
Durham, NC
Duke is a leading institution in infectious disease research, particularly in the area of dalbavancin, having co-led the DOTS trial and produced significant findings linking drug exposure to clinical success.
Key Differentiators
- Infectious Disease
-
#2
University of California, San Francisco (UCSF) Health
San Francisco, CA
UCSF played a crucial role as a co-lead in the DOTS trial and contributed significantly to the research and analysis of dalbavancin's effectiveness in treating bacteremia.
Key Differentiators
- Infectious Disease
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.